You really think that a globenews wire PR or two that just says "Dosing begins for second group in phase 1" and then 3 months later "No adverse effects in mid dosing group; highest dosing group next" Will get us to .30 to .50 cents PPS? That would be a rise from a 4 million to 50 million market cap? So far every PR has lowered the stock price.